Sign In
Buy SMTI
$20.97
-0.290 (-1.36%)
At Close: Jun 03, 2026
Sanara MedTech Inc. Reports Second Quarter 2025 Financial Results (Unaudited)
07:00am, Wednesday, 13'th Aug 2025
Net Revenue Increased 28% Year-Over-Year in Q2; Increased 27% Year-Over-Year in First Six Months of 2025 Announces Process to Evaluate Strategic Alternatives for its Tissue Health Plus, LLC Subsidia
Sanara MedTech to Report Second Quarter 2025 Financial Results on August 13, 2025
04:05pm, Tuesday, 15'th Jul 2025
FORT WORTH, TX, July 15, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc . (“Sanara,” or the “Company”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing trans
Sanara MedTech Inc. Announces Launch of Tissue Health Plus Wound Care Provider Pilot Program
04:05pm, Monday, 14'th Jul 2025
Pilot program designed to provide real-world evidence in the use of Tissue Health Plus' technology platform FORT WORTH, TX, July 14, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “
Sanara MedTech: Pursuing Rapid Expansion While Debt Levels Climb
06:22am, Monday, 09'th Jun 2025
Sanara MedTech's surgical revenue grew 26% year-over-year in Q1, with a gross margin of 92%. Surgical adjusted EBITDA was $2.7 million in Q1, while THP correspondingly posted a loss of $2 million. Hig
Sanara MedTech Inc. (SMTI) Q1 2025 Earnings Call Transcript
11:55am, Wednesday, 14'th May 2025
Sanara MedTech Inc. (NASDAQ:SMTI ) Q1 2025 Earnings Conference Call May 14, 2025 8:00 AM ET Company Participants Ron Nixon - Executive Chairman, Chief Executive Officer Seth Yon - President, Chief Com
Sanara MedTech Inc. (SMTI) Reports Q1 Loss, Tops Revenue Estimates
09:51am, Wednesday, 14'th May 2025
Sanara MedTech Inc. (SMTI) came out with a quarterly loss of $0.41 per share versus the Zacks Consensus Estimate of a loss of $0.31. This compares to loss of $0.21 per share a year ago.
Sanara MedTech Inc. Reports First Quarter 2025 Financial Results (Unaudited)
07:00am, Wednesday, 14'th May 2025
Q1 Net Revenue Increased 26% Year-Over-Year FORT WORTH, TX, May 14, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a me
Sanara MedTech to Report First Quarter 2025 Financial Results on May 14, 2025
08:00am, Wednesday, 23'rd Apr 2025
FORT WORTH, TX, April 23, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc . (“Sanara,” or the “Company”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing tran
Sanara MedTech to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025
04:00pm, Thursday, 10'th Apr 2025
FORT WORTH, TX, April 10, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on develo
Sanara MedTech (SMTI) Stock Jumps 8.1%: Will It Continue to Soar?
12:40pm, Thursday, 10'th Apr 2025
Sanara MedTech (SMTI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down
Sanara MedTech Inc. (SMTI) Q4 2024 Earnings Call Transcript
09:15am, Tuesday, 25'th Mar 2025
Sanara MedTech Inc. (NASDAQ:SMTI ) Q4 2024 Earnings Conference Call March 25, 2025 8:00 AM ET Company Participants Ron Nixon - Executive Chairman and Chief Executive Officer Seth Yon - President, Comm
Sanara MedTech Inc. Reports Fourth Quarter and Full Year 2024 Financial Results (Unaudited)
07:00am, Tuesday, 25'th Mar 2025
Q4 Net Revenue Increased 49% Year-Over-Year; 2024 Net Revenue Increased 33% Year-Over-Year FORT WORTH, TX, March 25, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “w
Sanara MedTech to Report Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025
04:05pm, Tuesday, 11'th Mar 2025
FORT WORTH, TX, March 11, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc . (“Sanara,” or the “Company”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing tran
Sanara MedTech: A Promising Growth Story At An Attractive Valuation
12:28pm, Thursday, 30'th Jan 2025
Shares have risen nearly 15% since the company posted preliminary Q4 results, which showed revenue up by 45-48% year over year. While growth was boosted by one-off demand for its BIASURGE product, und
SHANNON, Ireland, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Irish medical device company Biomimetic Innovations Limited, an affiliate of PBC Biomed, today announced the execution of an exclusive license and d
